Cogent Biosciences Overview
Cogent Biosciences Target Price
Analysts' 12-month price predictions for COGT.
Get informed when a big investor buys or sells
+ FollowShare Price
$36.31
Average Target Price
$50.00
37.7% upside
37.7% upside2 analysts in the last 4 months
High: $55 | Low: $45
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-01 | Stifel NicolausLaura Prendergast | $45 | 23.9% upside |  |
| 2026-05-06 | H.C. WainwrightRobert Burns | $55 | 51.5% upside | |
| 2026-02-19 | Robert W. Baird | $35 |  3.6% downside | |
| 2026-02-18 | Piper Sandler | $52 | 43.2% upside | |
| 2026-01-07 | UBSMichael Yee | $60 | 65.2% upside | |
| 2026-01-06 | H.C. Wainwright | $52 | 43.2% upside | |
| 2025-12-08 | Jefferies | $48 | 32.2% upside | |
| 2025-11-11 | Raymond JamesChris Raymond | $60 | 65.2% upside | |
| 2025-11-10 | Stifel Nicolaus | $40 | 10.2% upside | |
| 2025-11-10 | WedbushDavid Nierengarten | $38 | 4.7% upside | |
| 2025-10-15 | Stifel Nicolaus | $16 | 55.9% downside | |
| 2025-09-02 | Raymond James | $30 | 17.4% downside | |
| 2025-08-25 | Guggenheim | $20 | 44.9% downside | |
| 2025-01-14 | H.C. WainwrightRobert Burns | $14 | 61.4% downside | |
| 2024-09-24 | CitigroupDavid Lebowitz | $15 | 58.7% downside | |
| 2024-09-03 | CitigroupDavid Lebowitz | $13 | 64.2% downside | |
| 2024-09-03 | H.C. WainwrightRobert Burns | $17 | 53.2% downside | |
| 2024-03-30 | JefferiesKelly Shi | $20 | 44.9% downside | |
| 2022-12-14 | Needham | $24 | 33.9% downside | |
| 2022-06-17 | Raymond JamesChris Raymond | $22 | 39.4% downside | |
| 2022-06-10 | Leerink PartnersChristopher Liu | $15 | 58.7% downside | |